Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
EPMA Journal is Scopus-indexed (Q1, CiteScore 11.4), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 1878-5077Verify ISSN ↗1878-5085Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: About US$2,890 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Health Policy | 10 / 330 | 97th | Q1 |
| Drug Discovery | 20 / 161 | 87th | Q1 |
| Biochemistry (medical) | 10 / 78 | 87th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q1, CiteScore 11.4.
EPMA Journal is Q1 in Health Policy (rank 10 of 330), Q1 in Drug Discovery (rank 20 of 161) and Q1 in Biochemistry (medical) (rank 10 of 78), by CiteScore 2025.
EPMA Journal is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11.4, which places it in quartile Q1 at the 97th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.545, quartile Q1, with an H-index of 64.
The publisher lists an article processing charge of about US$2,890 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
EPMA Journal is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 1878-5077 and its online ISSN is 1878-5085.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
EPMA Journal has an h-index of 73 and a 2-year mean of 8.18 citations per paper (OpenAlex). Its Scopus CiteScore is 11.4, quartile Q1. On 2-year citations it ranks #8 of 327 Scopus journals in Health Policy.
EPMA Journal published 39 papers in 2025; its busiest recent year was 2022 with 44. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from China (56.2%), Germany (8.1%) and Australia (6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.